lymphoproliferativedisorderwithrisktodevelopasystemiclymphoma[J].Blood,2013,122(18):3101-3110.[18]COHENJI,MANOLII,DOWDELLK,etal.Hydroavacciniforme-likelymphoproliferativedisorder:anEBVdiseasewithalowriskofsystemicillnessinwhites[J].Blood,2019,133(26):2753-2764.[19]PLAZAJA,SANGUEZAM.Hydroavacciniforme-likelymphomawithprimarilyperiorbitalswelling:7casesofanatypicalclinicalmanifestationofthisrarecutaneousT-celllymphoma[J].AmJDermatopathol,2015,37(1):20-25.[20]MAGAÑAM,MASSONEC,MAGAÑAP,etal.Clinicopathologicfeaturesofhydroavacciniforme-likelymphoma:aseriesof9patients[J].AmJDermatopathol,2016,38(1):20-25.[21]RENF,ZHUJ,PERRYDM,etal.Hydroavacciniforme-likelymphoproliferativedisorder:aretrospectivecohortstudyofsevenpediatriccases[J].IntJDermatol,2020,59(8):e290-e292.[22]RUANYP,SHENXY,SHIRF,etal.Hydroavacciniforme-likelymphoproliferativedisordertreatedwithintravenousimmunoglobulin:long-termremissionwithouthaematopoieticstemcelltransplantationorchemotherapy[J].Advancesindermatologyandvenereology,2020,100(13):adv00192.[23]SAIDJ,SMARTC.Severemosquitobiteallergy:anunusualEBV+NKcelllymphoproliferativedisorder[J].Blood,2019,133(9):999.[24]LEES,PARKCJ,CHOYU,etal.ThefirstKoreancaseofEpstein-Barrvirus-positivenaturalkiller/T-celllymphomathatprogressedfromseveremosquitobiteallergy,withcoexistenceofhemophagocyticlymphohistiocytosis[J].AnnLabMed,2020,40(1):80-83.[25]LEEWI,LINJJ,HSIEHMY,etal.ImmunologicdifferencebetweenhypersensitivitytomosquitobiteandhemophagocyticlymphohistiocytosisassociatedwithEpstein-Barrvirusinfection[J].PLoSOne,2013,8(10):1-9.[26]CHENZH,WANGM,GUANPJ,etal.ComparisonofsystemicEBV-positiveT-CellandNK-celllymphoproliferativediseasesofchildhoodbasedonclassificationevolution:newclassification,oldproblems[J].AmJSurgPathol,2020,44(8):1061-1072.[27]MONTES-MOJARROIA,KIMWY,FENDF,etal.Epstein-BarrviruspositiveTandNK-celllymphoproliferations:morphologicalfeaturesanddifferentialdiagnosis[J].SeminDiagnPathol,2020,37(1):32-46.[28]COHENJI,IWATSUKIK,KOYH,etal.Epstein-BarrvirusN...
